Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

Gilead’s NASH hopes crushed as candidates fail again

Gilead’s NASH hopes crushed as candidates fail again As well as Novartis, other major pharma companies including Pfizer, Allergan, Merck &Co and Bristol-Myers Squibb are pursuing treatments in NASH.

Roche to close $4.3bn Spark deal after FTC clearance

Roche to close $4.3bn Spark deal after FTC clearance AbbVie said that there are “a few small product overlaps that we've agreed to divest promptly” ahead of its acqusition of Allergan to gain the FTC all-clear.

Sage slides off a MOUNTAIN as depression drug flunks trial

Sage slides off a MOUNTAIN as depression drug flunks trial Shortly after Spravato was approved, Allergan’s late-stage candidate  rapastinel – a weekly injectable drug targeting NMDA – bombed in three phase 3 trials.

CymaBay Therapeutics plummets after abandoning NASH drug

CymaBay Therapeutics plummets after abandoning NASH drug Other major pharma players looking to break into the NASH market first include Pfizer, Novartis, Allergan, Merck &Co and Bristol-Myers Squibb.

AbbVie sells $30bn of bonds ahead of Allergan merger

AbbVie sells $30bn of bonds ahead of Allergan merger AbbVie has sold $30bn worth of bonds to help fund its acquisition of Allergan, which was announced in in June this year. . ... The Allergan deal, he maintained, has a different purpose – to allow AbbVie to gain “critical mass” in its growth

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics